相关实验视频
Updated: Jul 16, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.2K
大脑-计算机接口缓解慢性化疗诱导的外周神经病变:一个随机,双盲,安慰剂对照试验
Sarah Prinsloo1,2, Ted J Kaptchuk3, Dirk De Ridder4
1Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer
|September 21, 2023
概括
神经反 (一个闭环脑电脑接口 (BCI)) 显著减少化疗诱导的外围神经病变 (CIPN) 症状. 这种BCI治疗显示出持久的效果,为患有神经疼痛的癌症幸存者提供了一个有希望的选择.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是癌症幸存者的一种慢性,使人衰弱的疾病.
- 之前的研究表明神经反 (闭环脑电脑接口 (BCI)) 在治疗CIPN时有效.
- 目前的研究假设BCI优于安慰剂和等待列表对照对CIPN缓解.
研究的目的:
- 为了评估BCI在减少CIPN症状方面的有效性,与安慰剂和等候名单对照相比.
- 为了确定大脑活动的变化是否预测症状的减少.
- 评估BCI治疗对CIPN的长期影响.
主要方法:
- 一项随机对照试验,涉及患有CIPN的乳腺癌幸存者.
- 参与者被分配到BCI,安慰剂控制 (PLC) 或等候名单控制 (WLC) 组.
- 治疗包括20次BCI或PLC治疗,治疗后和1个月后期评估结果.
主要成果:
- 与WLC相比,BCI和PLC组都显示出显著的症状减少.
- 比起PLC组,BCI组表现出更大的效果大小.
- 症状改善仅在BCI组持续1个月,大脑活动变化预测了这些结果.
结论:
- BCI是对CIPN的有希望的治疗方法,比安慰剂干预措施提供可能更持久的缓解.
- 了解安慰剂效应至关重要,但BCI证明了CIPN的特定治疗益处.
- 通过BCI的神经反可以修改大脑活动,以减轻癌症幸存者的持续神经疼痛.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
184
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
184
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
300
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
300
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
320
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
320
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
231
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
231

